Adage Capital Management, L.P. - Significant Ownership

Signature - Title
/s/ Robert Atchinson - By: Adage Capital Partners LLC, its General Partner, By: Robert Atchinson, its Managing Member
Location
Boston, MA
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Adage Capital Management, L.P..

Significant Ownership of Adage Capital Management, L.P.

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
DBVT DBV Technologies S.A. Ordinary Shares, nominal value 0.10 euro per share 9.99% $134M 14.6M Adage Capital Management, L.P. Jun 30, 2025
ABEO Abeona Therapeutics Inc. Common Stock, par value $0.01 per share 9.99% $28.3M $4.97M 5.35M +21.3% Adage Capital Management, L.P. Sep 30, 2025
MIST Milestone Pharmaceuticals Inc. Common Shares, no par value 9.99% $17.3M 8.66M Adage Capital Management, L.P. Sep 30, 2025
CABA Cabaletta Bio, Inc. Common Stock, par value $0.00001 per share 9.99% $13.7M 9M Adage Capital Management, L.P. Jun 30, 2025
INO Inovio Pharmaceuticals, Inc. Common Stock, par value $0.001 per share 9.99% $12.9M 5.52M Adage Capital Management, L.P. Sep 30, 2025
EQ Equillium, Inc. Common Stock, par value $0.0001 per share 9.99% $8.6M 6.01M Adage Capital Management, L.P. Sep 30, 2025
IMUX Immunic, Inc. Common stock, par value $0.0001 per share 9.99% $7.31M $6.33M 10.5M +649% Adage Capital Management, L.P. Jun 30, 2025
IBIO iBio, Inc. Common Stock, par value $0.001 per share 9.99% $1.74M 2.18M Adage Capital Management, L.P. Sep 30, 2025
MNPR Monopar Therapeutics Common Stock, par value $0.001 per share 9.86% $20.9M 599K Adage Capital Management, L.P. Dec 31, 2024
WVE Wave Life Sciences Ltd. Ordinary Shares, no par value 9.65% $97.6M $16.3M 15M +20% Adage Capital Management, L.P. Jun 30, 2025
EYPT EyePoint Pharmaceuticals, Inc. Common Stock, par value $0.001 per share 8.07% $79.2M -$17.7M 5.56M -18.2% Adage Capital Management, L.P. Sep 30, 2025
Talon Capital Corp. Class A Ordinary Shares, par value $0.0001 per share 7.89% 2.03M Adage Capital Management, L.P. Sep 30, 2025
LATAU Galata Acquisition Corp. II Class A Ordinary Shares, par value $0.0001 per share 7.83% $13.5M 1.35M Adage Capital Management, L.P. Sep 30, 2025
Highview Merger Corp. Class A ordinary shares, par value $0.0001 per share 7.61% 1.8M Adage Capital Management, L.P. Sep 30, 2025
OTGAU OTG Acquisition Corp. I Class A Ordinary Shares, par value $0.0001 per share 7.57% $18.1M 1.8M Adage Capital Management, L.P. Sep 30, 2025
CNTA Centessa Pharmaceuticals plc Ordinary shares, nominal value 0.002 GBP per share 7.48% $243M $39.6M 10M +19.4% Adage Capital Management, L.P. Sep 30, 2025
MNRO Monro, Inc. Common Stock, par value $0.01 per share 7.41% $39.9M 2.22M Adage Capital Management, L.P. Sep 30, 2025
ADGM Adagio Medical Holdings, Inc. Common Stock, par value $0.0001per share 6.88% $2.14M $479K 1.06M +28.9% Adage Capital Management, L.P. Sep 30, 2025
AMLX Amylyx Pharmaceuticals, Inc. Common Stock, $0.0001 par value per share 6.39% $92.6M -$27M 6.82M -22.5% Adage Capital Management, L.P. Sep 30, 2025
PRQR ProQR Therapeutics N.V. Ordinary Shares, nominal value 0.04 euro per share 6.27% $13.5M -$3.06M 6.6M -18.5% Adage Capital Management, L.P. Jun 30, 2025
DRUG Bright Minds Biosciences Inc. Common Shares, no par value 5.58% $24M 396K Adage Capital Management, L.P. Sep 30, 2025
PRAX Praxis Precision Medicines, Inc. Common Stock, par value $0.0001 per share 5.29% $69.2M -$56.7M 1.31M -45% Adage Capital Management, L.P. Oct 31, 2025
NPB NORTHPOINTE BANCSHARES INC Common Stock, no par value 5.22% $30.7M 1.79M Adage Capital Management, L.P. Sep 30, 2025
MGTX MeiraGTx Holdings plc Ordinary Shares, par value $0.00003881 per share 5.2% $34.4M 4.18M Adage Capital Management, L.P. Sep 30, 2025
KPTI Karyopharm Therapeutics Inc. Common Stock, par value $0.0001 per share 5.18% $3.93M 6.55M Adage Capital Management, L.P. Dec 31, 2024
SLDB Solid Biosciences Inc. Common Stock $0.001 par value per share 5.14% $24.7M -$16.8M 4M -40.6% Adage Capital Management, L.P. Sep 30, 2025
SDRL Seadrill Ltd Common Shares, par value $0.01 per share 5.04% $82.4M -$27.9M 3.14M -25.3% Adage Capital Management, L.P. Jun 30, 2025
CDTX Cidara Therapeutics, Inc. Common Stock, par value $0.0001 per share 4.97% $53.6M $5.36M 1.1M +11.1% Adage Capital Management, L.P. Jun 30, 2025
ACRS Aclaris Therapeutics, Inc. Common Stock, par value $0.00001 per share 4.87% $10M -$5.55M 5.28M -35.6% Adage Capital Management, L.P. Sep 30, 2025
TRAW Traws Pharma, Inc. Common Stock, par value $0.01 per share 4.67% $624K 330K 0% Adage Capital Management, L.P. Sep 30, 2025
FULC Fulcrum Therapeutics, Inc. Common Stock, par value $0.001 per share 4.5% $22.4M -$19.8M 2.43M -47% Adage Capital Management, L.P. Sep 30, 2025
JANX Janux Therapeutics, Inc. Common Stock, $0.001 par value per share 4.27% $58.3M -$12.4M 2.53M -17.5% Adage Capital Management, L.P. Jun 30, 2025
ZVRA Zevra Therapeutics, Inc. Common Stock, par value $0.0001 per share 3.96% $21.2M -$13.6M 2.23M -39% Adage Capital Management, L.P. Sep 30, 2025
ALGS Aligos Therapeutics, Inc. Voting Common Stock, par value $0.0001 per share 3.9% $1.51M -$829K 210K -35.4% Adage Capital Management, L.P. Jun 30, 2025
ZEO Zeo Energy Corp. Class A Common Stock, par value $0.0001 per share 3.22% $2.2M 760K Adage Capital Management, L.P. Jun 30, 2025
ENSC Ensysce Biosciences, Inc. Common Stock, par value $0.0001 per share 3.15% $167K 74.7K 0% Adage Capital Management, L.P. Jun 30, 2025
ENGN enGene Holdings Inc. Common Shares, with no par value per share 3% $6.12M 1.53M Adage Capital Management, L.P. Dec 31, 2024
URGN UroGen Pharma Ltd. Ordinary Shares, par value NIS 0.01 per share 2.77% $12.3M -$15.9M 1.28M -56.4% Adage Capital Management, L.P. Mar 31, 2025
SLNO SOLENO THERAPEUTICS INC Common Stock, par value $0.001 per share 2.64% $94.7M -$147M 1.4M -60.8% Adage Capital Management, L.P. Sep 30, 2025
AEVA Aeva Technologies, Inc. Common Stock, par value $0.0001 per share 2.56% $10.3M 1.4M Adage Capital Management, L.P. Mar 31, 2025
TCRX TScan Therapeutics, Inc. Voting Common Stock, par value $0.0001 per share 2.52% $1.96M 1.35M Adage Capital Management, L.P. Jun 30, 2025
TNGX Tango Therapeutics, Inc. Common Stock, par value $0.001 per share 2.26% $21.1M -$28.5M 2.51M -57.5% Adage Capital Management, L.P. Sep 30, 2025
BBOT BridgeBio Oncology Therapeutics, Inc. Common Stock, par value $0.0001 per share 1.88% $17.1M 1.49M Adage Capital Management, L.P. Sep 30, 2025
MREO Mereo BioPharma Group plc Ordinary Shares, nominal value 0.003 GBP per share 1.07% $16.6M 8.5M Adage Capital Management, L.P. Mar 31, 2025
ETHM Dynamix Corp Class A Ordinary Shares, par value $0.0001 per share 0.75% $1.3M -$12.8M 125K -90.7% Adage Capital Management, L.P. Sep 30, 2025
LXEO Lexeo Therapeutics, Inc. Common Stock, par value $0.0001 per share 0.7% $426K -$3.53M 238K -89.2% Adage Capital Management, L.P. Mar 31, 2025
GLYCOMIMETICS INC Ordinary Shares, par value $0.001 per share 0.37% 50.9K Adage Capital Management, L.P. Jun 20, 2025
TARA Protara Therapeutics, Inc. Common Stock, par value $0.001 per share 0% $0 -$8.78M 0 -100% Adage Capital Management, L.P. Mar 31, 2025
ETNB 89bio, Inc. Common Stock, par value $0.001 per share 0% $0 -$134M 0 -100% Adage Capital Management, L.P. Oct 29, 2025
INZY Inozyme Pharma, Inc. Common Stock, par value $0.0001 per share 0% $0 0 Adage Capital Management, L.P. Jun 30, 2025
STR Sitio Royalties Corp. Class A Common Stock, par value $0.0001 per share 0% $0 -$113M 0 -100% Adage Capital Management, L.P. Sep 30, 2025

Schedules 13D/G Reported by Adage Capital Management, L.P.:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.